Novartis AG
(NYSE : NVS)

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.31%165.950.7%$1319.81m
LLYEli Lilly & Co. -0.44%332.701.1%$1038.19m
PFEPfizer Inc. -0.28%44.270.9%$799.00m
BMYBristol-Myers Squibb Co. 0.00%72.061.0%$784.71m
ABBVAbbVie, Inc. -0.18%144.301.9%$780.31m
MRKMerck & Co., Inc. -0.82%86.080.7%$697.20m
AZNAstraZeneca Plc -0.07%54.651.0%$436.74m
NVSNovartis AG -1.43%75.220.2%$218.10m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%210.768.2%$210.83m
GSKGSK Plc -0.80%29.220.3%$204.39m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.115.4%$190.67m
NVONovo Nordisk A/S 1.46%100.830.1%$178.16m
HZNPHorizon Therapeutics Plc -0.55%63.495.4%$169.03m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.13%152.140.0%$158.36m
SGENSeagen Inc. 0.00%137.725.7%$129.81m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.